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OBJECTIVES: To identify hypertension prescription patterns in
a Los Angeles County Latino population, evaluate prevalence of
use of foreign antihypertensive drugs, and its association with
blood pressure control. METHODS: Data was obtained from
the Los Angeles Latino Eye Study (LALES), a study designed to
assess the prevalence of eye disease and self-reported visual func-
tion in Latinos age 40 and older. In total, 1076 patients with self-
reported history of hypertension, clinic blood pressure values
and available medication proﬁle of drugs taken within the past
month were identiﬁed for analysis. Antihypertensive drugs were
identiﬁed and assessed for origin as US or foreign (Mexican,
Central or South American), drug class, and total number of
antihypertensives used. Chi-square tests were used to test for dif-
ferences between US and foreign drug groups in terms of uti-
lization of different drug classes, demographic differences, and
blood pressure control. RESULTS: Only 50.5% (533/1076) of
subjects with history of hypertension were on at least one anti-
hypertensive medication. 34.9% of subjects had taken two or
more antihypertensives in the past month. A total of 30.2%
(161/533) had taken a beta-blocker within the previous month,
32.8% (175/533) an ACE-inhibitor, and 25.0% (133/533) a
calcium channel blocker. The prevalence of foreign and US sup-
plied drug use were 1.5% (16/1076) and 48.0% (517/1076)
respectively. The difference in blood pressure control between the
US and foreign drug use groups was not statistically signiﬁcant
(p = 0.1160). CONCLUSIONS: Although foreign medications
may be easily accessible, there does not appear to be signiﬁcant
use of foreign antihypertensive medications within this Los
Angeles Latino population. The relationship between foreign
drug use and blood pressure control was not found to be statis-
tically signiﬁcant but the result may be due to the limited number
of foreign drug use observations.
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OBJECTIVES: To assess type, duration, and medication avail-
ability of antihypertensive therapy among veterans. METHODS:
Electronic medical records from the Central Texas Veterans
Health Care System were extracted for adults newly diagnosed
with hypertension between 1995 and 2003. Information on
demographic (age, gender, and race/ethnicity) and clinical (diag-
noses, height, weight, labs, and blood pressure values) charac-
teristics were collected. Drug utilization was measured as a
time-dependent variable; thus, the use of combination therapies
was captured for any given day for each patient in the sample.
Medication availability was calculated as the ratio of “total days
supply” and “number of days between ﬁrst and last reﬁll.”
RESULTS: The average age of the participants (N = 11,187) was
60.7 (SD: 12.7). Half (50.1%) of the patients could be catego-
rized as having controlled blood pressure. Veterans were fol-
lowed for an average of 3.6 years (total of 51,549 person-years).
Overall, 29,561 treatment episodes were identiﬁed; an average
of about 2.6 per patient. Over forty percent (41.6%) of these
episodes involved one medication only, but patients frequently
used dual (26.9%) and three or more (15.9%) combination ther-
apies. Patients took “single therapy alone” for a median of 1.3
years, “dual therapies alone” for a median of 1.0 years, whereas
“three or more therapies” for a median of 0.9 years. Medication
availability ratios were relatively high, ranging from 0.88 to
0.93. Overall, calcium channel blockers (22.4%), angiotensin
converting enzyme inhibitors (21.4%), and beta-blockers
(19.9%) were used most frequently. CONCLUSIONS: Our
results indicate high medication availability ratios; i.e., veterans
ﬁlled their antihypertensive medications as it was prescribed 
by their physicians. Nevertheless, the average blood pressure
control rate was only 50 percent, which requires improvements
in patients’ antihypertensive therapy. The necessity of better
selection of antihypertensive therapies is also supported by the
ﬁnding of frequent therapy changes.
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OBJECTIVES: Despite inherent limitations, administrative
claims databases have been widely used to assess quality of care
and evaluate medical care appropriateness in several therapeutic
areas including hypertension (HTN). The objective of this study
was to assess the validity of two commonly used claims-based
algorithms in identifying the presence of HTN, using patient
medical records (MR) as the gold standard. METHODS:
Managed care claims data spanning January 1, 2000 through
March 31, 2003 were used. HTN patients (test-positives) were
identiﬁed using two algorithms—algorithm A used medical
claims only and algorithm B used both pharmacy and medical
claims. Test-positives and test-negatives (health plan members
without HTN medical claims in algorithm A and without a HTN
medical AND pharmacy claim in algorithm B) were 1 :1 matched
on their propensity for having a HTN claim. Propensity scores
were computed using a logistic regression model including demo-
graphic, clinical and physician characteristics to allow for mul-
tivariate matching. MR were reviewed for the presence of HTN,
and the validity of claims-based criterion was evaluated by com-
puting its sensitivity and speciﬁcity, and comparing with MR
data. RESULTS: A total of 258 and 138 matched pairs of test-
positives and test-negatives for algorithms A and B, respectively,
were identiﬁed. Baseline characteristics were similar for test-pos-
itives and test-negatives. The sensitivity (95% CI) and speciﬁcity
(95% CI) of algorithm A were calculated as 71% (65.1–76.1)
and 75% (68.8–80.3) respectively, and those of algorithm B were
76% (69.1–82.3) and 93.3 (86.6–97.3) respectively. The kappa
score for assessing strength of agreement between claims data
and MR was 0.45 for algorithm A and 0.65 for algorithm B.
CONCLUSION: The results demonstrate the validity of using
claims based algorithms in identifying hypertensive patients.
However, the higher sensitivity and speciﬁcity of algorithm B
demonstrate that using a combination of medical and pharmacy
claims will help reduce the risk of patient misclassiﬁcation, when
compared with using medical claims only.
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OBJECTIVE: To assess the advantages and limitations of using
a web-based survey to obtain patient-reported outcomes (PRO).
METHODS: A web-based patient survey was conducted in a
population diagnosed with hypertension to assess the correlation
between blood pressure control and patients’ satisfaction with
antihypertensive treatment. Patients were selected from the
